Health — Alzheimers — August 13th, 2026

Alzheimer's markers show crucial differences across diverse global populations
Established Alzheimer's markers are also detected in blood samples from Nigeria and Tanzania. But other proteins in the blood differ from those seen in a comparable group in Canada. This is important if blood tests for Alzheimer's are to be used globally.
August 13th, 2026 — Source

Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's risk
Women on regimens of estrogen-only menopausal hormone therapy are at reduced risk of Alzheimer's disease, a study by Stanford Medicine investigators has found. Because estrogen-only therapy is generally prescribed for women without a uterus, most of these users presumably had had hysterectomies.
August 13th, 2026 — Source

Health — Alzheimers — August 12th, 2026

Blood-thinning medication linked to slower cognitive decline
People with both atrial fibrillation and Alzheimer's disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline. This is shown by a study from Karolinska Institutet published in the European Heart Journal.
August 12th, 2026 — Source

Brain inflammation may cast a long dementia shadow in older survivors of encephalitis
Encephalitis is a serious condition in which an infection or autoimmune response triggers inflammation of the brain. The resulting swelling can disrupt normal brain function, causing neurological changes such as confusion, altered mental status and seizures. Researchers from The University of Texas Medical Branch wanted to see whether the aftermath of encephalitis left the brain vulnerable to other neurological conditions. They studied a very large group of people in the United States using anonymous electronic health records from 72 health care organizations.
August 12th, 2026 — Source

Health — Alzheimers — August 9th, 2026

Early Alzheimer's patients pursuing lecanemab show low adherence to brain health advice
Researchers at the Mass General Brigham Neuroscience Institute found that most patients with early Alzheimer's disease are not optimally adhering to recommendations for improving their brain health, including exercising, getting adequate sleep, preventing hypertension and eating a heart-healthy diet. The results, published in The Journal of Prevention of Alzheimer's Disease, show that fewer than 3% of the studied patients followed all 15 brain health recommendations the researchers examined. Both patients with early Alzheimer's disease who pursued treatment with lecanemab, an anti-amyloid antibody medication for Alzheimer's disease, and patients who did not pursue anti-amyloid therapy had poor adherence to brain health recommendations, with no significant difference between the groups.
August 9th, 2026 — Source

Health — Alzheimers — August 5th, 2026

MRI metric identifies early, multifactorial white matter damage in Alzheimer's disease
Alzheimer's disease has traditionally been studied as a condition that primarily affects the brain's gray matter, where neuronal cell bodies are located and some of the disease's most characteristic lesions accumulate. However, growing evidence indicates that white matter is also affected during the early stages of the neurodegenerative process.
August 5th, 2026 — Source

New metric detects early Alzheimer's changes in brain's white matter
Alzheimer's disease has traditionally been studied as a condition that primarily affects the brain's gray matter, where neuronal cell bodies are located and some of the disease's most characteristic lesions accumulate. However, growing evidence indicates that white matter is also impacted during the early stages of the neurodegenerative process.
August 5th, 2026 — Source

Health — Alzheimers — August 3rd, 2026

Two new compounds could reveal hidden drivers of Alzheimer's disease
Vanderbilt researchers created the first selective compound designed to inhibit TAOK-1, a poorly understood protein connected to Alzheimer's disease. They also discovered a second compound that activates the entire TAOK protein family, offering scientists an unexpected new research tool. Together, the compounds could reveal hidden disease mechanisms and point toward new treatment strategies.
August 3rd, 2026 — Source

Health — Alzheimers — July 31st, 2026

Mighty mitochondria: Scientists uncover new role for fighting bacterial infections, including drug-resistant superbugs
Beyond the nucleus, no other organelle in eukaryotic cells captures the public's imagination quite like mitochondria: They are the engines of cellular energy production; they possess their own DNA, and they are passed from generation to generation from mothers to offspring.
July 31th, 2026 — Source

Newly identified mitochondrial plaques provide potential therapeutic target for Alzheimer's disease
Alzheimer's disease is a devastating neurodegenerative disorder affecting millions of people worldwide. Scientists have long known that two hallmarks of the disease are beta-amyloid (A&beta) plaques and neurofibrillary tangles, which damage and kill brain cells over time. A University of Minnesota research team has identified a type of plaque that represents a potential new therapeutic target for Alzheimer's disease.
July 31th, 2026 — Source

Health — Alzheimers — July 29th, 2026

Less sugar early in life may reduce the risk of Alzheimer's
Sugar restriction during the first 1,000 days after conception may significantly reduce a person's risk of developing Alzheimer's by up to 46%. Those are the findings of a new study published in the journal npj Aging that examined the long-term effects of early-life nutrition on brain aging and lifelong mental health. The findings also suggest that some benefits may begin before birth.
July 29th, 2026 — Source

Health — Alzheimers — July 27th, 2026

Amyloid beta misfolding predicts Alzheimer's years before symptoms appear
Widely used Alzheimer's biomarker P-tau 217 reliably detects the disease only at the clinical stage. The protein misfolding of amyloid beta indicates an increased risk years earlier.
July 27th, 2026 — Source

Study tracks risk factors for Alzheimer's disease and dementias in South Asian Americans
Members of diasporas across the world, such as the large Indian diaspora, are influenced by the food and lifestyle of the countries where they live. The new societal factors they experience, together with differences in their genetic makeup, often uniquely affect their health outcomes for diseases like Alzheimer's and dementia. Comprehensive risk-assessment studies of various diasporas are needed to develop research and policies that address emerging health issues arising from global population movements.
July 27th, 2026 — Source

What repeated blows to the head in sport may mean for dementia risk
The latest—preliminary research presented at the Alzheimer's A8ssociation International Conference in July 2026—examined 142 former professional footballers ages 30--60 and 56 people of a similar age who had no history of contact sports or repeated head impacts.
July 27th, 2026 — Source or Watch Video

Health — Alzheimers — July 24th, 2026

Microglia found to drive sleep loss in Alzheimer's
There's a small fire isolated in your kitchen. If you had the right tool, you might be able to put it out. But before you can, the sprinklers turn on and flood your entire house. An automatic response to an issue has now damaged everything you own.
July 24th, 2026 — Source

Health — Alzheimers — July 22nd, 2026

Dog Photographer Loses Copyright Case Over AI-Generated Comic Version of Her Image
A photographer, specializing in underwater dog portraits, has lost a copyright case over an AI-generated comic-style image, created from one of her photo — with a court ruling it did not infringe her work.
July 22nd, 2026 — Source

Frailty could be key to early dementia diagnosis
Being frail appears to accelerate the onset of dementia, particularly in people who show little or no signs of the disease, a University of Queensland-led study has found. Dr. David Ward from UQ's Frazer Institute said the findings suggest frailty could be an important independent clinical marker to help diagnose and potentially treat dementia.
July 22nd, 2026 — Source

Lab-grown mini brains may predict which Alzheimer's treatments will work
Miniature brain models grown from patients' cells revealed striking differences in how Alzheimer's-related tissue responds to an antidepressant. The organoids and the particles they release could eventually guide more personalized treatments and provide new clues for diagnosing the disease.
July 22nd, 2026 — Source

New study uses sleep monitoring and AI to detect Alzheimer's
Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganes, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer's. The study, recently published in the scientific journal GeroScience, demonstrates that analyzing nocturnal brain waves using machine learning techniques makes it possible to non-invasively identify early neural alterations and classify patients into three distinct biological subgroups.
July 22nd, 2026 — Source

Three genetic modifiers may alter inherited Alzheimer's onset and progression
Autosomal dominant Alzheimer's disease (ADAD) is a genetically inherited form of Alzheimer's disease that accounts for only about 1% of Alzheimer's disease cases. However, because individuals with the gene mutations are extremely likely to develop Alzheimer's disease at an early age, and because the mutation is highly heritable, ADAD is widely studied by Alzheimer's disease researchers.
July 22nd, 2026 — Source

Health — Alzheimers — July 16th, 2026

Study links sleeping long hours with higher levels of an Alzheimer's-related protein
Regularly sleeping long hours each night is associated with higher levels of an Alzheimer's-related protein in the blood, even after accounting for other health factors, a new study from UT Health San Antonio, the academic health center of The University of Texas at San Antonio, suggests.
July 16th, 2026 — Source

WHO updates guidelines to reduce risk of dementia worldwide
The World Health Organization (WHO) today released updated guidelines on reducing the risk of cognitive decline and dementia, providing countries with evidence-based recommendations to help prevent or delay the onset of dementia across the life course.
July 16th, 2026 — Source

Health — Alzheimers — July 12th, 2026

Alzheimer's tau protein has a surprising secret role in memory
Researchers found that tau is essential for turning new experiences into lasting memories by helping organize the brain's memory-storing cells. The mouse study also revealed how abnormal tau may contribute to Alzheimer's by disrupting both the formation of new memories and the recall of existing ones.
July 12th, 2026 — Source

Dementia risk factors look different around the world, large study finds
A major, USC-led study of more than 214,000 older adults across 14 countries and regions finds that the most common controllable risk factors for dementia—such as low education, high blood pressure and smoking—vary widely from country to country, meaning a one-size-fits-all approach to prevention won't work everywhere.
July 12th, 2026 — Source

Health — Alzheimers — July 9th, 2026

New global Alzheimer's disease country insights tool reveals major inequalities in diagnosis, treatment access and preparedness across countries
Alzheimer's Disease International (ADI) has launched the Alzheimer's Disease Atlas (AD Atlas), a first of its kind platform highlighting how countries diagnose, treat and support people living with dementia. The platform brings together the key indicators needed to assess a country's preparedness for Alzheimer's disease and related dementias, helping advocates, policymakers and healthcare leaders identify where people are being left behind.
July 9th, 2026 — Source

Spear Bio to unveil novel Alzheimer's disease immunoassays and fully automated instrument platform at AAIC 2026
Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay and instrument innovations at the Alzheimer's Association International Conference® 2026, taking place July 12--15 in London, UK.
July 9th, 2026 — Source

Health — Alzheimers — July 8th, 2026

Investigational drug that targets DNA damage help could treat Alzheimer's disease
Using a mouse model of Alzheimer's disease, investigators found that treatment with KCL-286, a molecule that activates the retinoic acid receptor-beta (RAR&beta), enhanced the repair of DNA damage in neurons. Activation of the receptor triggers a pathway that ultimately causes a protein complex to bind to DNA and promote the expression of certain repair genes. KCL-286 also reduced neuronal inflammation and abnormal brain immune activity, processes thought to contribute to Alzheimer's disease development and progression.
July 8th, 2026 — Source or Source

New comprehensive data platform could transform Alzheimer's research, treatment
New comprehensive data platform could transform Alzheimer's research, treatment
July 8th, 2026 — Source

Health — Alzheimers — July 2nd, 2026

BCG vaccine may rewire brain immunity, shift Alzheimer's markers over 12 months
New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guerin (BCG) vaccine—which is delivered through the skin to prevent tuberculosis—may remodel the human brain's immune environment, offering a potential biological explanation for previously observed associations between BCG vaccination and lower Alzheimer's disease risk. Findings are published in Communications Medicine.
July 2nd, 2026 — Source

Dementia-causing substance turns into a therapeutic 'switch' with new Alzheimer's drug strategy
A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new therapeutic approach that uses hydrogen peroxide (H₂O₂), a reactive oxygen species that damages cells and increases in the brains of patients with Alzheimer's disease, to activate a drug selectively in diseased brain tissue. The team also confirmed improvements in cognitive function through animal experiments, presenting a new possibility for next-generation dementia treatment.
July 2nd, 2026 — Source

USC scientists target brain inflammation to prevent Alzheimer's disease
An interdisciplinary team at the USC Center for Personalized Brain Health (CPBH) is targeting a family of enzymes that can increase the risk of inflammation in the brains of people with the APOE4 gene variation-the most significant genetic risk factor for late-onset Alzheimer's-as a way to prevent the disease.
July 2nd, 2026 — Source

Health — Alzheimers — June 26th, 2026

New Alzheimer's drugs offer hope for some, but good dementia care protects the humanity of those they cannot help
Unlike older dementia drugs, which help with symptoms but do not change the underlying disease, disease-modifying treatments are designed to slow the disease process itself. So far, these treatments appear to delay symptom progression by several months rather than years. They also carry a small but serious risk of side effects, including swelling and bleeding in the brain. At present, they are suitable only for some people in the early stages of Alzheimer's disease, meaning that many others will still face dementia with no cure on the horizon.
June 26th, 2026 — Source

Health — Alzheimers — June 22nd, 2026

Could nighttime light affect brain health? Researchers investigate Alzheimer's links
A growing body of research suggests that sleep may be more than a symptom of Alzheimer's disease—it may also play a role in how the disease develops and progresses. Now, new research from the University of Kentucky's Sanders-Brown Center on Aging is shedding light on how everyday environmental factors and inflammation in the brain could influence sleep, circadian rhythms and Alzheimer's-related changes.
June 22nd, 2026 — Source

Molecular cause of age-related cognitive decline identified
A research team from University Hospitals, Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center has identified a critical molecular cause of age-related cognitive decline, potentially paving the way for new treatments to protect brain health as people age.
June 22nd, 2026 — Source

RNA biomarkers identified that could offer a simple blood test for earlier Alzheimer's diagnosis
An estimated 55 million people worldwide are living with Alzheimer's disease, according to Alzheimer's Disease International. Yet diagnosis remains challenging because symptoms often overlap with those of other conditions, and current diagnostic methods can be costly or invasive. Blood-based biomarkers could support routine clinical use while reducing the need for lumbar puncture and positron emission tomography (PET) imaging.
June 22nd, 2026 — Source

Health — Alzheimers — June 20th, 2026

Dementia care: Re‑envisioning the role of music
As a certified music therapist, I have observed firsthand the many ways music can bring meaning and beauty into people's lives, even under very difficult circumstances. Much of my clinical work and research has occurred in dementia care. Here, music is often described as an inexpensive non-pharmacological treatment for behavioral and psychological symptoms with no side effects.
June 20th, 2026 — Source

Health — Alzheimers — June 19th, 2026

Scientists reprogram brain immune cells to fight Alzheimer's
A newly identified molecule called OLE helped restore the brain's immune cells to a more protective state in Alzheimer's models. The treatment reduced toxic plaque buildup and improved memory, raising hopes for a new therapeutic approach.
June 19th, 2026 — Source

Health — Alzheimers — June 15th, 2026

Brain workouts both inside and outside school walls may shape dementia risk
The experiences children have in classrooms, at home and in their communities may help build a cognitive buffer that protects against or delays dementia later in life. A new University of Michigan study published in Alzheimer's & Dementia proposes a new way of thinking about how childhood education affects Alzheimer's risk—looking beyond just years of schooling to examine the quality of schools, home learning environments and students' sense of belonging and confidence in the classroom.
June 15th, 2026 — Source

Health — Alzheimers — June 10th, 2026

Low blood pressure shows strongest link to Alzheimer's disease
Numerous types of cardiovascular disease and CVD risk factors were linked to a higher risk of Alzheimer's disease, with low blood pressure showing the strongest connection, according to a new analysis published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
June 10th, 2026 — Source

Health — Alzheimers — June 8th, 2026

Hay fever, antihistamines and the evidence on dementia risk
For millions of people around the world, pollen season means weeks of sneezing, itchy eyes, and a blocked or runny nose. The timing varies depending on where you live and which plants are in flower, but grass pollen is one of the most common triggers.
June 8th, 2026 — Source

New drug could slow the development of Alzheimer's
"Compound 10" is how Ursula Quitterer refers to the chemical compound that her team has developed and that could slow the progression of Alzheimer's disease. Quitterer is a professor of molecular pharmacology at ETH Zurich and has so far tested the active ingredient first in mice, revealing promising effects: The typical death of nerve cells seen in dementia is significantly slower, and the animals survive longer.
June 8th, 2026 — Source

Postoperative delirium serves as strongest predictor of cognitive decline
Researchers found postoperative delirium was strongly associated with long-term cognitive decline and the effect was not explained by rehospitalizations, highlighting the long-term impact of delirium on brain health.
June 8th, 2026 — Source or Source

Health — Alzheimers — June 6th, 2026

Antibody fragment prevents hemorrhages associated with new Alzheimer's treatments
In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (Leqembi™, from Biogen) and donanemab (Kisunla, from Eli Lilly and Co.), both based on immunotherapy (the use of molecules from the immune system to treat diseases). These antibodies, obtained in the laboratory, act against the A&beta peptide, a protein fragment that accumulates in the brains of patients with Alzheimer's disease. Elimination of this protein by the immune system helps slow the characteristic cognitive decline of the disease.
June 6th, 2026 — Source

PET imaging links brain metabolism patterns to effectiveness of Alzheimer's disease treatment
A specific pattern of brain metabolism visualized with PET imaging can predict which patients are most likely to benefit from Alzheimer's disease therapy. In a retrospective study of patients who received Alzheimer's treatments, those with the identified pattern experienced stabilized cognitive performance, while patients with other patterns had significant cognitive decline. This study was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 Annual Meeting, where it received top recognition as the Abstract of the Year.
June 6th, 2026 — Source

Health — Alzheimers — June 5th, 2026

Antibody fragment offers safer alternative for Alzheimer disease treatment
In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM, from Biogen) and donanemab (KisunlaTM, from Eli Lilly and Company), both based on immunotherapy (the use of molecules from the immune system to treat diseases). These antibodies, obtained in the laboratory, act against the A&beta peptide, a protein fragment that accumulates in the brain of patients with Alzheimer's disease. The fact that the immune system eliminates this protein helps slow the characteristic cognitive decline of the disease.
June 5th, 2026 — Source

Senior Care Authority kicks off Alzheimer's and Brain Awareness Month with six science-backed habits that may help reduce dementia risk
An estimated 7.4 million Americans aged 65 and older are now living with Alzheimer's disease, according to the Alzheimer's Association's 2026 Alzheimer's Disease Facts and Figures report, and that number is projected to climb to nearly 13 million by 2050. Yet the same report found that while 99% of adults say brain health is as important as physical health, only 9% say they know enough about how to maintain it.
June 5th, 2026 — Source

Health — Alzheimers — May 30th, 2026

Blood test with AI spots four dementia-related brain diseases with 92.3% accuracy
Many people living with dementia never receive an accurate diagnosis, in part because Alzheimer's disease, Parkinson's disease and related conditions are notoriously difficult to tell apart and often occur together. Now, a new tool based on artificial intelligence and a simple blood draw may provide clarity.
May 30th, 2026 — Source

Inside Alzheimer's neurons, tau may set off a genetic chain reaction that ends in cell death
Alzheimer's disease is a neurodegenerative disease characterized by a progressive decline in mental functions and memory loss. Along with frontotemporal dementia and some other neurodegenerative disorders, Alzheimer's disease has been associated with an accumulation inside neurons of abnormal clumps of a protein called "tau."
May 30th, 2026 — Source

Health — Alzheimers — May 29th, 2026

Protein traffic jams may explain aging, memory loss, and Alzheimer's
Scientists at Stanford may have uncovered a hidden reason our brains decline with age. Studying the ultra-short-lived turquoise killifish, researchers discovered that the cellular machinery responsible for building proteins begins to jam and malfunction over time. Tiny structures called ribosomes start colliding and stalling while reading genetic instructions, triggering a chain reaction that leads to faulty proteins and harmful clumps linked to diseases like Alzheimer's.
May 29th, 2026 — Source

Scientists uncover how Alzheimer's may quietly begin years before memory loss appears
A new Columbia study has found clues of Alzheimer's beginnings, revealing how tau filaments—protein clumps that are closely linked to memory decline in Alzheimer's disease—get their start. The finding raises the prospect of future Alzheimer's drugs that could stop the production of the filaments at its source. The findings are published in the journal Nature Neuroscience.
May 29th, 2026 — Source

Health — Alzheimers — May 28th, 2026

Brain imaging study highlights ethnoracial differences in dementia
A large multisite study of older people with cognitive impairment finds that Black and Hispanic people, while known to be far more apt to have dementia, are significantly less apt than other racial and ethnic groups to show Alzheimer's pathology on brain scans. The study, reported in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, was led by researchers at Vanderbilt Health.
May 28th, 2026 — Source

Health — Alzheimers — May 24th, 2026

Blood biomarkers could detect earliest signs of Alzheimer's disease—and slow its progression
Alzheimer's disease, a progressive neurodegenerative disorder that affects millions worldwide, has a long preclinical stage. It potentially begins decades before clinical symptoms become apparent.
May 24th, 2026 — Source

Health — Alzheimers — May 22nd, 2026

Nitric oxide rewires gene expression in the brain, offering new insight into Alzheimer's disease
Genes undergo extensive editing through a process called alternative splicing, which greatly increases the size of the functional genome—the working portion of our DNA that helps make each person unique. Put simply, a single gene can be edited in different ways to produce multiple sets of instructions. This helps explain why humans differ so significantly from fruit flies and mice, despite having a similar number of genes.
May 22nd, 2026 — Source

Health — Alzheimers — May 21st, 2026

Finding the early signs of Alzheimer's disease
New research from the University of Otago—Ōtākou Whakaihu Waka has uncovered another clue to potentially identifying Alzheimer's disease early. Using data from the Dunedin Multidisciplinary Health and Development Study's age 45 assessments, researchers investigated a specific biomarker in blood plasma, ptau181, which has been shown in other studies to be strongly associated with Alzheimer's disease in later life.
May 21st, 2026 — Source

Researchers develop index to analyze uneven atrophy of brain regions due to Alzheimer's disease
Alzheimer's disease begins to weave a web in the brain and remodel neuronal tissue 15 to 20 years before the first symptoms appear. From the time this happens, however, until the disease is diagnosed and, later, enters an advanced phase, it progresses along a continuum of changes to the brain. Now, an international team with Universitat Oberta de Catalunya (UOC) participation has developed a method for detecting variations in this continuum, which makes it possible to accurately assess the progression of dementia.
May 21st, 2026 — Source

Simple blood test could catch Alzheimer's and Parkinson's early by spotting misfolded proteins
For the first time, therapeutically effective medications are now available for Alzheimer's disease. Effective symptomatic therapies also exist for Parkinson's disease; however, a prerequisite for successful treatment is early diagnosis—ideally through a simple blood test conducted as part of a preventive screening, even before clinical symptoms appear.
May 21st, 2026 — Source

Health — Alzheimers — May 18th, 2026

Blood metabolite patterns could reveal dementia risk in midlife
A simple blood-based measure of biological aging could help identify people at higher risk of dementia long before memory problems begin, offering a potential new tool for earlier prevention and targeted intervention.
May 18th, 2026 — Source

Poor sleep tied to Alzheimer's risk in older women
Sleep complaints may be an important Alzheimer's disease risk factor in older women with a higher genetic predisposition to the disease, according to a new study from researchers at the University of California San Diego. The findings suggest that women with a higher genetic risk for Alzheimer's who reported poorer sleep also showed greater memory difficulties and more Alzheimer's-related brain changes.
May 18th, 2026 — Source

Smog exposure tied to nearly fourfold higher Lewy body dementia risk
Long-term exposure to smog might increase the risk of Lewy body dementia, the brain disease that CNN founder Ted Turner battled for several years before his recent death, a new study says.
May 18th, 2026 — Source

Statistical method may overstate Alzheimer's drugs' cognitive benefits by 29 times
A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.
May 18th, 2026 — Source

Health — Alzheimers — May 17th, 2026

Scientists reverse Alzheimer's in mice with breakthrough nanotechnology
Scientists reversed Alzheimer's-like symptoms in mice using smart nanoparticles that reboot the brain's natural waste-clearing system.
May 17th, 2026 — Source

Health — Alzheimers — May 15th, 2026

Better brain health linked to resilience against early Alzheimer's in adults 65 to 80
A healthy brain may help protect thinking and memory skills from the early effects of Alzheimer's disease, a new study has found. Dementia is currently the leading cause of death in Australia and Alzheimer's disease is its most common form—accounting for more than 70% of cases.
May 15th, 2026 — Source

Researchers investigate whether dementia tests miss signs in autistic adults
Researchers are investigating whether existing dementia assessment methods may overlook signs of cognitive decline in autistic adults because many screening tools were developed around neurotypical populations.
May 15th, 2026 — Source

Health — Alzheimers — May 10th, 2026

Ultrasensitive test detects biomarkers for specific form of dementia
Dementia affects over 57 million people worldwide, a number expected to nearly double in the next 20 years. This permanent loss of cognitive abilities affects daily function and can be caused by multiple brain pathologies, including well-known ones like Alzheimer's disease (AD). Right now, biomarkers permit diagnosis of AD, but not rarer pathologies like frontotemporal lobar degeneration (FTLD) or its subtypes.
May 10th, 2026 — Source

Using the body's own sounds to diagnose Alzheimer's and Parkinson's before the first symptoms appear
Long before the telltale signs of Parkinson's disease appear, including tremors and muscle stiffness, there are other, more subtle signs of the disease.
May 10th, 2026 — Source

Health — Alzheimers — May 4th, 2026

This simple amino acid supplement greatly reduces Alzheimer's damage
A common, low-cost amino acid could become an unexpected new weapon against Alzheimer's.
May 4th, 2026 — Source

Ultrafast MRI uncovers brain signal direction: New scan may help decode autism, Alzheimer's and hallucinations
Researchers at the Champalimaud Foundation in Lisbon have for the first time managed to identify with an imaging technique whether nervous impulses in the brain of rats are flowing in a "bottom-up" (feedforward), carrying information about visual input, or a "top-down" (feedback) direction, carrying information about expectations or predictions on a given task or about the perception of the world around us.
May 4th, 2026 — Source

Health — Alzheimers — April 27th, 2026

Not all Alzheimer's leads to dementia: The mystery of cognitive resilience
Some brains resist Alzheimer's, even when the disease is already present. Researchers at the Netherlands Institute for Neuroscience have found that this likely depends on how specific brain cells, known as immature neurons, respond to damage caused by the disease. These insights are helping scientists unravel the mystery of cognitive resilience in aging.
April 27th, 2026 — Source

Health — Alzheimers — April 26th, 2026

Smell loss may mark Alzheimer's start as olfactory damage map comes into focus
A research team has, for the first time, identified at the cellular level why the olfactory system is the first to be damaged in the early stages of Alzheimer's disease (dementia). The paper is published in the journal Alzheimer's & Dementia. The team was led by Prof. Moon Cheil of the Department of Brain Sciences at the Daegu Gyeongbuk Institute of Science and Technology, in collaboration with a team led by Prof. Ali Jahanshahi at Maastricht University in the Netherlands.
April 24th, 2026 — Source

Weight-loss drugs could tackle Alzheimer's—study
A new study has found comprehensive evidence that "weight-loss" GLP-1 receptor agonists such as semaglutide are effective in tackling the biological drivers of Alzheimer's disease. The study, published in the journal Molecular and Cellular Neuroscience, examined 30 preclinical studies investigating the effects of four GLP-1 receptor agonists—liraglutide; semaglutide; exenatide; and dulaglutide—on Alzheimer's disease pathology.
April 24th, 2026 — Source

Health — Alzheimers — April 23rd, 2026

Metabolic health may shape future dementia risk for Latino communities
Researchers from the University of California San Diego have found that diabetes is linked to changes in measurable biological signals in the blood that are associated with Alzheimer's disease and brain damage in Latino adults.
April 23rd, 2026 — Source or Source

Severe strokes significantly increase the risk of progressive dementia
As stroke severity increases, the risk of progressive cognitive decline and dementia substantially escalates, according to a national study led by Michigan Medicine researchers.
April 23rd, 2026 — Source

Health — Alzheimers — April 21st, 2026

Early immune changes may signal increased risk of Alzheimer's and dementia
Circulating white blood cells called neutrophils are some of the immune system's first responders. Their numbers shoot up during infection and inflammation, shifting the ratio of neutrophils to other types of immune cells in the blood.
April 21st, 2026 — Source

Health — Alzheimers — April 17th, 2026

Study suggests some Alzheimer's symptoms may begin outside the brain
UCF researchers have uncovered evidence that some movement-related symptoms of Alzheimer's disease may originate outside the brain, which could change how the disease is diagnosed and treated in the future.
April 17th, 2026 — Source

Health — Alzheimers — April 14th, 2026

Blood test can predict Alzheimer's disease progression years before symptoms or brain scan changes
A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid PET scan changes and cognitive decline in cognitively healthy older adults. The findings may help push back the clock to enable simpler, earlier disease prediction and indicate who may be at risk for cognitive decline.
April 14th, 2026 — Source

Lonely people have worse memory but don't decline faster, study finds
Loneliness may weaken memory—but it doesn't seem to speed up cognitive decline.
April 14th, 2026 — Source

Health — Alzheimers — April 11th, 2026

New biological marker of early-stage Alzheimer's disease uncovered
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and a decline in mental functions. These symptoms are known to arise from an abnormal buildup of proteins known as amyloid and tau, which can damage or gradually destroy neurons and the connections between them.
April 11th, 2026 — Source

New drug combination doubles down on Alzheimer's treatments
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more effective way to treat the disease.
April 11th, 2026 — Source

Your nose could detect Alzheimer's years before symptoms begin
Early Alzheimer's may quietly begin with the loss of smell, driven by the brain's own immune system attacking key neural connections.
April 11th, 2026 — Source

Health — Alzheimers — April 9th, 2026

Scientists discover hidden gut trigger behind ALS and dementia
A hidden culprit in the gut may be driving devastating brain diseases—and scientists just found a way to fight back.
April 9th, 2026 — Source

Scientists just found a hidden "drain" inside the human brain
Scientists just uncovered a hidden brain "trash system"—and it could change everything about how we fight Alzheimer's and brain disease.
April 9th, 2026 — Source

Somatostatin in brain regulates immune cells to mitigate dementia, opening path for treatment with existing drugs
A research team led by Professor Jiwon Um from the Center for Synapse Diversity and Specificity at DGIST has discovered a mechanism by which somatostatin, a brain neurotransmitter, directly regulates brain immune cells to alleviate Alzheimer's disease. This study is expected to provide a strong foundation for repurposing existing medications for dementia treatment by shifting brain immune cells that worsen the condition into a "protective mode."
April 9th, 2026 — Source

Swapping passive screen time with mental activity may cut dementia risk
Swapping passive screen time for mentally engaging activities may help protect the brain over decades, offering new insight into how everyday habits shape dementia risk.
April 9th, 2026 — Source

Health — Alzheimers — April 8th, 2026

High-dose flu vaccine reduces Alzheimer's risk in older adults
A stronger flu shot might do more than prevent infection. New research suggests it could modestly lower Alzheimer's risk, especially in older women, offering fresh insight into brain health and prevention.
April 8th, 2026 — Source

Higher optimism linked to lower dementia risk
In the analysis of data from the Health and Retirement Study, a nationally representative sample of older US adults, optimism was assessed using the validated Life Orientation Test-Revised in 9,071 cognitively healthy individuals within 2 years of obtaining each person's first measure of cognitive function. Dementia was assessed during up to 14 years of follow-up.
April 8th, 2026 — Source

Tau seeds spread through connected neurons in people with Alzheimer's disease, new research shows
Researchers have discovered the mechanism by which neurofibrillary tangles spread through the brain of Alzheimer's patients is via connected neurons, and these findings reveal a major disease etiology that could lead to new therapies that slow Alzheimer's disease progression.
April 8th, 2026 — Source

Health — Alzheimers — April 3rd, 2026

How an Alzheimer's risk gene disrupts brain circuits long before memory loss
For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their brain activity may begin changing long before any memory problems appear. Now, researchers at Gladstone Institutes have uncovered a precise chain of molecular events behind those early changes and identified a potential way to reverse them.
April 3rd, 2026 — Source

Researchers uncover a chain of molecular events behind early brain changes in Alzheimer's
For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their brain activity may begin changing long before any memory problems appear. Now, researchers at Gladstone Institutes have uncovered a precise chain of molecular events behind those early changes and identified a potential way to reverse them.
April 3rd, 2026 — Source

Health — Alzheimers — April 2nd, 2026

Eating more meat may lower Alzheimer's risk for some people
A surprising new study suggests that genetics may change how diet affects brain health—especially when it comes to Alzheimer's risk. Researchers found that older adults carrying high-risk APOE gene variants didn't show the expected cognitive decline if they ate relatively high amounts of meat. In fact, those with these genes who consumed the most meat had slower cognitive decline and lower dementia risk, challenging conventional dietary advice.
April 2nd, 2026 — Source

Health — Alzheimers — April 1st, 2026

Discontinued childhood growth hormone treatment linked to rare cases of Alzheimer's
Alzheimer's disease (AD) is a neurodegenerative disorder that takes away a person's memory, thinking skills, and eventually the ability to perform basic tasks. A recent study has provided further evidence that the disease could be transmitted through rare childhood medical treatments that are no longer used today.
April 1st, 2026 — Source

Gut microbiome changes improve memory in early cognitive decline
From Mediterranean diets to probiotics, scientists reveal how reshaping the gut microbiome could help protect brain function, while highlighting why timing may be critical for slowing cognitive decline.
April 1st, 2026 — Source

Simple blood test could spot dementia years earlier, research shows
Scientists have discovered that subtle changes in the blood may reveal the earliest signs of cognitive decline long before symptoms become obvious.
April 1st, 2026 — Source

Health — Alzheimers — March 31st, 2026

How time and space become one inside your brain—and what it means for Alzheimer's
If you develop Alzheimer's disease, you not only lose your sense of time, but you also lose your sense of place. Could time and place be two sides of the same coin? About 55 million people globally are currently living with dementia, such as Alzheimer's disease, a number that is expected to triple by 2050. At the Institute of Basic Medical Sciences at the University of Oslo, researchers are working to get closer to understanding what happens in the brain, so that we can prevent or slow the development of such diseases.
March 31st, 2026 — Source

Mirror image proteins offer new way to disable Alzheimer's disease
Understanding how proteins interact with their own mirror images enabled a Kobe University research team to design a small mirror protein that disables a causal factor of Alzheimer's disease, amyloid-beta.
March 31st, 2026 — Source or Source

Health — Alzheimers — March 24th, 2026

Scientists say NAD+ could slow aging and fight Alzheimer's and Parkinson's
A global team of leading scientists is zeroing in on a tiny but powerful molecule that could reshape how we age. Known as NAD⁺, it plays a crucial role in keeping our cells energized, repairing DNA, and maintaining overall health—but its levels steadily decline over time, potentially fueling diseases like Alzheimer's and Parkinson's. Researchers are now exploring ways to boost NAD⁺ using compounds like NR and NMN, with early studies hinting at improvements in memory, metabolism, and physical function.
March 24th, 2026 — Source

Health — Alzheimers — March 20th, 2026

Weight-loss drug semaglutide does not slow Alzheimer's disease, two clinical trials find
Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the first large Phase III randomized controlled trials on the topic published in The Lancet.
March 20th, 2026 — Source

Health — Alzheimers — March 18th, 2026

Nasal swab test spots early Alzheimer's signals
Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new treatments may work best. In a new study, Duke Health researchers show that a quick, outpatient nasal swab can pick up early biological changes linked to Alzheimer's, even before thinking and memory problems appear.
March 18th, 2026 — Source

New data platform tracks the complex path to Alzheimer's and could transform how its risk is predicted
A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD), reports a new study at Columbia University Mailman School of Public Health and collaborators at the Vagelos College of Physicians and Surgeons, the School of Nursing as well as the University of Miami and University of Chicago.
March 18th, 2026 — Source or Source

Health — Alzheimers — March 16th, 2026

The Alzheimer's gut-brain link: How butyrate could curb amyloid-&beta buildup and inflammation
Alzheimer's disease (AD) is a neurodegenerative disease that causes progressive memory loss and a significant decline in mental functions. Past studies have shown that people with AD exhibit a buildup of a protein called amyloid-&beta (A&beta), forming deposits known as amyloid plaques that disrupt communication between neurons.
March 16th, 2026 — Source

Workshop to examine ethical sharing of research data in Alzheimer's and related dementias
Researchers from academia, federal agencies and national organizations, and participants enrolled in research studies focused on neurodegenerative diseases such as Alzheimer's disease will gather at Georgia State University for a scientific retreat that seeks to advance ethical data and sample sharing practices to accelerate scientific advancements.
March 16th, 2026 — Source

Health — Alzheimers — March 13th, 2026

Novel compounds open new research avenues for Alzheimer's disease therapeutics
Alzheimer's disease is the most common cause of dementia, and it affects over 7 million people in the United States alone. Although there are treatments that can slow its progression, most of them treat its symptoms only and none of them can cure the disease.
March 13th, 2026 — Source

Health — Alzheimers — March 12th, 2026

A surprising blood protein pattern may reveal Alzheimer's
A new blood test may detect Alzheimer's earlier by spotting subtle changes in the shape of proteins in the bloodstream.
March 12, 2026 — Source

Certain neurons are especially susceptible to ALS and frontotemporal dementia, researchers discover
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia, and other serious impairments. There are currently no effective treatments.
March 12, 2026 — Source

Major genetic risk factor for rare form of dementia identified
Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
March 12, 2026 — Source

New study identifies specific brain cells most vulnerable to ALS and dementia
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia, and other serious impairments. There are currently no effective treatments. Many patients have a common hallmark: A protein called TDP-43 clumps together in the neurons of the brain to form tiny lumps. Researchers at DZNE and Ulm University Hospital, together with international experts, have now discovered that these pathological changes primarily affect certain cells.
March 12, 2026 — Source

Health — Alzheimers — March 11th, 2026

Blood marker for Alzheimer's may also be useful in heart and kidney diseases
A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders. Researchers at DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen have found that elevated levels of phosphorylated tau protein (pTau) also occur in two lesser-known conditions that primarily affect the heart and kidneys.
March 11, 2026 — Source

Blood marker linked to Alzheimer's also found in systemic amyloidosis
A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders. Researchers at DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen have found that elevated levels of phosphorylated tau protein (pTau) also occur in two lesser-known conditions that primarily affect the heart and kidneys.
March 11, 2026 — Source

Health — Alzheimers — March 5th, 2026

Brain-clearing cells offer clues to slowing Alzheimer's disease progression
Accumulation of the protein tau in the brain is one of the hallmarks of Alzheimer's disease. In a paper published in Cell Press Blue, researchers report a previously unknown mechanism that appears to enable the buildup of tau. The study, which employed animal and cellular models as well as patient tissues, suggests a key role for tanycytes—specialized brain cells that regulate brain-body signaling.
March 5, 2026 — Source

Enhanced brain cells clear away dementia-related proteins
The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend independent living for patients by 10 months. Called monoclonal antibodies, they reduce the accumulation of a harmful protein, amyloid, in the brain and require high-dose, once- or twice-monthly infusions of the medication.
March 5, 2026 — Source

Health — Alzheimers — March 4th, 2026

Protein linked to Parkinson's may drive faster Alzheimer's disease progression in women
Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson's-related protein, according to a Mayo Clinic study published in JAMA Network Open. The same pattern was not observed in men.
March 4, 2026 — Source

Health — Alzheimers — March 2nd, 2026

A new class of Alzheimer's biomarkers: Why protein shape may beat protein levels
Researchers have identified a new type of blood-based biomarker test for Alzheimer's disease that measures structural changes in proteins, providing more information on the underlying biology of the disease than standard blood tests. The findings, published in Nature Aging, also provide new insights into how Alzheimer's disease biology may differ between males and females.
March 2, 2026 — Source

Key DNA changes in the brains of people with Alzheimer's disease identified
In a study published in Nature Communications, Mayo Clinic researchers have identified specific DNA-level changes in the brains of people with Alzheimer's disease (AD). Using advanced biological analysis, the team mapped alterations in the brain's regulatory landscape that may help explain why Alzheimer's presents and progresses differently from person to person.
March 3, 2026 — Source

Low‑dose oral lithium may help slow the decline of verbal memory, trial suggests
Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization.
March 2, 2026 — Source or Source

New paper examines dementia inequities in Indigenous communities and the power of cultural resilience
An international collaboration, co-led by a University of Minnesota Medical School researcher, has published a paper in Alzheimer's & Dementia synthesizing global evidence on the origins of dementia inequities in Indigenous communities and how community strengths can inform brain health research worldwide.
March 2, 2026 — Source

Specific protein and sugar molecules affected by aging and disease identified
Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that predispose the brain to synaptic dysfunction and proteinopathy (neurodegenerative diseases characterized by the abnormal folding, aggregation, and accumulation of specific proteins within neurons or brain tissues).
March 3, 2026 — Source

Supposedly harmless peptide may be linked to Alzheimer's disease
While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting amyloid beta due to its role in clogging patients' brains with harmful deposits, a biochemist at the University of California, Santa Cruz, says the peptide has a smaller, overlooked "cousin" that could also be neurotoxic.
March 2, 2026 — Source

Tau tangles may hijack brain's energy, linking early sleep loss to Alzheimer's changes
Scientists at the University of Kentucky have uncovered a new reason why people with Alzheimer's disease often struggle with sleep, long before memory loss begins. The study, led by researchers at the Sanders-Brown Center on Aging, reveals that a protein called tau "hijacks" the brain's energy supply, keeping the brain in a state of overactive excitability that prevents restorative rest.
March 3, 2026 — Source

Health — Alzheimers — February 24th, 2026

Alzheimer's may begin with a silent drop in brain blood flow
Subtle changes in brain blood flow and oxygen use are closely linked to hallmark signs of Alzheimer's, including amyloid plaques and memory-related brain shrinkage. Simple, noninvasive scans may one day help spot risk earlier—by looking at the brain's vascular health, not just its plaques.
February 24, 2026 — Source

How urinary tract infections can trigger delirium and worsen dementia
Although urinary tract infections (UTIs) are typically minor—albeit painful—health issues for most people, they can pose serious risks for older adults, particularly those with Alzheimer's disease and other forms of dementia. In older patients, a common UTI can trigger delirium, a medical emergency marked by sudden confusion and altered awareness. This condition can not only accelerate cognitive decline but is often mistaken for an underlying neurological condition—delaying proper diagnosis and treatment.
February 24, 2026 — Source

New lab technique can reverse chemical process linked with Alzheimer's disease
An Oregon State University scientist and a team of undergraduate students have uncovered real-time insights into a chemical process linked with Alzheimer's disease, paving the way toward better drug designs. The researchers used a molecule measuring technique to observe in a laboratory setting how certain metals can promote the protein clumping that leads to the blocked neural pathways associated with Alzheimer's. Led by Marilyn Rampersad Mackiewicz, associate professor of chemistry in the OSU College of Science, the research team also watched molecules known as chelators disrupt or reverse the clumping.
February 24, 2026 — Source

Novel markers of brain blood flow and oxygenation may offer early clues to Alzheimer's risk
Subtle changes in how blood flows through the brain and how brain tissue uses oxygen may be closely linked to Alzheimer's disease risk, according to new research from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC.
February 24, 2026 — Source

Reading peptides one amino acid at a time through a sub-nanometer pore
A pore smaller than one nanometer reads peptide sequences amino acid by amino acid, pinpointing single-site Alzheimer's mutations and modifications with single-residue resolution.
February 24, 2026 — Source

Health — Alzheimers — February 17th, 2026

Scientists discover brain switches that clear Alzheimer's plaques
Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer's disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects.
February 17, 2026 — Source

The good side of a side effect: Brain swelling during Alzheimer's treatment may signal strong response
A new Alzheimer's treatment side effect that results in brain swelling may have an upside, according to a new study from Houston Methodist Research Institute. The research finds that beta amyloid—a protein that accumulates as plaques in the brain—may be cleared more in brain regions that had this side effect, signaling a stronger treatment response.
February 17, 2026 — Source

Health — Alzheimers — February 15th, 2026

AI uncovers the hidden genetic control centers driving Alzheimer's
AI-powered gene maps reveal the hidden control networks reshaping the Alzheimer's brain.
February 15, 2026 — Source

Health — Alzheimers — February 14th, 2026

Menopause, hormones and the brain: How hormone therapy could help protect against Alzheimer's
As dementia and other neurodegenerative diseases become more common worldwide, researchers are searching urgently for ways to protect the brain as we age. One area attracting growing attention is hormones, particularly the role of hormone therapy during and after menopause.
February 14, 2026 — Source

Health — Alzheimers — February 13th, 2026

Causal gene mapping identifies key drivers of Alzheimer's disease progression
Researchers led by Min Zhang and Dabao Zhang of the University of California, Irvine's Joe C. Wen School of Population & Public Health have created the most detailed maps to date showing how genes causally regulate one another across different types of brain cells affected by Alzheimer's disease.
February 13, 2026 — Source

Health — Alzheimers — February 12th, 2026

AI-built maps reveal causal gene regulation across Alzheimer's brain cell types
Researchers led by Min Zhang and Dabao Zhang of the University of California, Irvine's Joe C. Wen School of Population & Public Health have created the most detailed maps to date showing how genes causally regulate one another across different types of brain cells affected by Alzheimer's disease.
February 12, 2026 — Source

Early cognitive stimulation preserves memory in Alzheimer's
A team from the Institute of Neurosciences of the University of Barcelona (UBneuro) has discovered that early and sustained cognitive stimulation can help preserve brain connectivity and memory in Alzheimer's disease, even in advanced stages of the pathology. The study, published in the journal iScience and carried out with animal models, also reveals that males respond better than females to cognitive intervention to delay the onset of the disease.
February 12, 2026 — Source

Simple SMS 'nudge' a powerful prompt for timely vaccination
10,000 families participating in research by The Kids Research Institute Australia have demonstrated the effectiveness of a simple text message for increasing the number of children receiving their vaccinations on time. Throughout 2021--2024, over 20,000 text messages were sent to Australian parents as part of the AuTOMATIC trial—thought to be the most automated clinical trial ever conducted.
February 12, 2026 — Source

Health — Alzheimers — February 11th, 2026

Depression may be the brain's early warning sign of Parkinson's or dementia
Depression in older adults may sometimes signal the early stages of Parkinson's disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains elevated long afterward, unlike in other chronic illnesses. This suggests depression may reflect early brain changes rather than emotional distress alone.
February 11, 2026 — Source

Health — Alzheimers — February 6th, 2026

Dementia collaborative care delivers greater value than Alzheimer's medication
Programs that match caregivers with patient navigators yield better outcomes than Alzheimer's drug -- but combining the two may be best.
February 6, 2026 — Source

Preclinical study successfully reverses loss of blood flow to brain, an early sign of Alzheimer's disease
Supriya Chakraborty might have been studying insects in a lab had it not been for an immunology college instructor in India who taught him about the superheroes inside him—immune cells that wage a battle against bacteria, parasites, and a host of other adversaries that invade our bodies. "That really fascinated me," Chakraborty recalled. "My focus shifted from entomology to wanting to solve illnesses that affect humans, specifically neurodegenerative disorders."
February 6, 2026 — Source

Health — Alzheimers — February 4th, 2026

A 25-year study found an unexpected link between cheese and dementia
A massive Swedish study tracking nearly 28,000 people for 25 years found an unexpected link between full-fat dairy and brain health. Among adults without a genetic risk for Alzheimer's, eating more full-fat cheese was associated with a noticeably lower risk of developing the disease, while higher cream intake was tied to reduced dementia risk overall. The findings challenge decades of low-fat dietary advice but come with important caveats.
February 4, 2026 — Source

Battling the other 'Alzheimer's protein': What drives neurodegenerative tauopathies and how to treat them
Battling the other 'Alzheimer's protein': What drives neurodegenerative tauopathies and how to treat them
February 4, 2026 — Source

How our lab is helping develop an Alzheimer's test that can be done at home
Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and a test sent in the post. This may sound like science fiction, but we are hoping our research could soon help it become a reality.
February 4, 2026 — Source

One-third of dementia cases are linked to non brain-related diseases, study finds
Dementia is a term used to describe memory loss, impaired reasoning, difficulties communicating and other mental impairments that can be caused by Alzheimer's disease, other neurodegenerative disease, strokes, severe infections, head injuries or various other conditions. While most past studies investigating the causes and underpinnings of dementia focused on the brain, a growing body of research suggests that these mental impairments could sometimes be linked to diseases that affect other parts of the body, referred to as peripheral diseases.
February 4, 2026 — Source

Health — Alzheimers — January 31st, 2026

Signs of Sir Terry Pratchett's dementia may have been hidden in his books
Signs of Sir Terry Pratchett's dementia may have been present in his writing a decade before his official diagnosis, new research has found. Researchers have examined the lexical diversity—a measure of how varied an author's word choices are—of 33 books from Pratchett's Discworld series, focusing specifically on his use of nouns and adjectives.
January 31, 2026 — Source

Health — Alzheimers — January 9th, 2026

APOE gene: A major driver in Alzheimer's disease
Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers.
January 9, 2026 — Source or Source

Sex-based differences and role of BMP signaling in neurogenesis in Alzheimer's mice models
Alzheimer's disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows sex-based differences, with women being more at risk. However, the origin of these differences remains unknown. While bone morphogenetic proteins (BMPs) play an important role in adult neurogenesis, their role in AD remains elusive. To address this, researchers have investigated sex-based differences and role of BMP signaling in neurogenesis in AD mice models, uncovering novel therapeutic targets.
January 9, 2026 — Source

Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer's disease
Alzheimer's disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows sex-based differences, with women being more at risk. However, the origin of these differences remains unknown.
January 9, 2026 — Source

Health — Alzheimers — January 6th, 2026

Alzheimer's symptoms often diverge from tau levels, study suggests
One of the biggest challenges in treating Alzheimer's disease (AD) is how heterogeneous it is in terms of speed of decline and presence of other pathologies. That is, more than 50% of people with AD have other pathologies that influence how fast or slow cognitive decline will be.
January 6, 2026 — Source

Study highlights effect of Alzheimer's, frontotemporal dementia on subcortical brain structures
A recent study by the Laboratory for Neuro-Analysis and Imaging (LANAI) at UMass Chan Medical School highlights how subcortical brain structures degenerate in Alzheimer's disease and frontotemporal dementia patients.
January 6, 2026 — Source

Successful 40-Hz auditory stimulation in aged monkeys suggests potential for noninvasive Alzheimer's therapy
A research team from the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences has demonstrated for the first time in non-human primates that auditory stimulation at 40 Hz significantly elevates &beta-amyloid levels in the cerebrospinal fluid (CSF) of aged rhesus monkeys, with this effect persisting for over five weeks.
January 6, 2026 — Source

Health — Alzheimers — January 5th, 2026

Protein disposal system may accelerate Alzheimer's by transferring toxins between brain cells
A research group led by Professor Michael Glickman, dean of Technion's Faculty of Biology, has uncovered a key mechanism in the development of Alzheimer's. The mechanism in question identifies toxic proteins and disposes of them.
January 5, 2026 — Source

Remote Alzheimer's testing: At-home blood tests can accurately detect key biomarkers
A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger-prick blood samples that can be collected at home and mailed to laboratories without refrigeration or prior processing.
January 5, 2026 — Source

Your Samsung Watch could soon help spot dementia in its earliest stages
New health feature coming to Galaxy Watches.
January 5, 2026 — Source

Health — Alzheimers — December 25th, 2025

Scientists found a way to restore brain blood flow in dementia
Replacing a missing brain molecule restored blood flow in new research, pointing to a promising new approach for treating dementia.
December 25, 2025 — Source

Health — Alzheimers — December 19th, 2025

The 98% mystery: Scientists just cracked the code on "junk DNA" linked to Alzheimer's
Researchers have revealed that so-called "junk DNA" contains powerful switches that help control brain cells linked to Alzheimer's disease. By experimentally testing nearly 1,000 DNA switches in human astrocytes, scientists identified around 150 that truly influence gene activity—many tied to known Alzheimer's risk genes. The findings help explain why many disease-linked genetic changes sit outside genes themselves. The resulting dataset is now being used to train AI systems to predict gene control more accurately.
December 19, 2025 — Source

Health — Alzheimers — December 15th, 2025

Study establishes practical definition for rapidly progressive dementia
A new multicenter study led by Mayo Clinic researchers has established a practical, evidence-based definition of rapidly progressive dementia (RPD), a rare but devastating form of cognitive decline that develops over months instead of years.
December 15, 2025 — Source

Health — Alzheimers — December 12th, 2025

Framework can improve Alzheimer's treatment efficacy by tracking anti-A&beta therapy response
In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-A&beta). These monoclonal anti-A&betas are proteins made in a laboratory to stimulate the immune system to slow the progression of the disease by targeting amyloid plaques in the brain that are characteristic of Alzheimer's.
December 12, 2025 — Source

Health — Alzheimers — December 11th, 2025

Brain stimulation during sleep boosts weak memories in mice
Manipulating mouse brains during sleep improved their ability to remember new experiences that would normally be forgotten—a finding with important implications for treating Alzheimer's disease and other forms of dementia that act on similar processes.
December 11, 2025 — Source

Plasma p-tau217 can reliably detect preclinical Alzheimer disease
Michael Malek-Ahmadi, Ph.D., from the University of Arizona College of Medicine-Phoenix, and colleagues conducted a systematic literature review to identify published studies that compared amyloid-positive and amyloid-negative older adults without cognitive impairment. A meta-analysis was conducted to assess the standardized effect size of mean differences and classification accuracy of p-tau217.
December 11, 2025 — Source

Transfusing blood from old mice accelerates Alzheimer's progression in an animal model
Alzheimer's disease is the most common form of dementia worldwide and continues to be one of the greatest public health challenges. New research, published in the journal Aging, reveals that blood from aged mice can accelerate the progression of the disease, while young blood may have protective effects. The study was led by researchers from Instituto Latinoamericano de Salud Cerebral (BrainLat) at Universidad Adolfo Ibáñez in conjunction with MELISA Institute, the University of Texas Health Science Center at Houston, and Universidad Mayor.
December 11, 2025 — Source

Health — Alzheimers — December 5th, 2025

Alzheimer's blood tests may be misleading for people with kidney problems
A large study found that people with impaired kidneys tend to have higher Alzheimer's biomarkers, yet they don't face a higher overall risk of dementia. For those who already have elevated biomarkers, kidney problems may speed up when symptoms appear. The findings show that kidney health can change how Alzheimer's blood tests are read. Doctors may need to consider both organs to get a clearer picture.
December 5, 2025 — Source

Alzheimer's changes appear early in patients with Down syndrome
Down syndrome is caused by an extra copy of chromosome 21. Because of genes present on this chromosome that are known to contribute to Alzheimer's disease, patients with Down syndrome often develop the disease, sometimes at a relatively young age. However, few studies have examined Alzheimer's-related pathological changes in the brains of people with Down syndrome, especially pediatric patients and those who are Black or Hispanic. Studies also hadn't explored other neurodegenerative conditions in those with Down syndrome.
December 5, 2025 — Source

Loss of brain protein eases Alzheimer's symptoms and brain damage in mice
New research published in the journal eNeuro examined whether eliminating a protein that is elevated in the brains of those with Alzheimer's could prevent or reduce damage and behavioral symptoms in a mouse model of Alzheimer's disease.
December 5, 2025 — Source

Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain.
December 5, 2025 — Source

Health — Alzheimers — December 3rd, 2025

A routine shingles shot may offer powerful defense against dementia
A lucky natural experiment suggests the shingles vaccine may powerfully reduce, and even slow, dementia.
December 3, 2025 — Source

Breaking down barriers to accessing dementia-friendly eyecare
New accessible resources aim to make it easier for people with dementia and their families to access dementia-friendly eyecare.
December 3, 2025 — Source

Hidden cellular layers in the hippocampus' CA1 region revealed
Researchers at the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have identified a previously unknown pattern of organization in one of the brain's most important areas for learning and memory. The study, published in Nature Communications, reveals that the CA1 region of a mouse's hippocampus, a structure vital for memory formation, spatial navigation, and emotions, has four distinct layers of specialized cell types.
December 3, 2025 — Source

Just 20 minutes of exercise twice a week may help slow dementia, study finds
How much physical activity—and how often—is needed to help stall dementia? For older adults with mild cognitive decline, there is now an answer: at least 20 minutes, at least twice weekly.
December 3, 2025 — Source

Poor kidney health linked to higher levels of Alzheimer's biomarkers in blood
People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk of dementia, according to a study published in Neurology.
December 3, 2025 — Source

Health — Alzheimers — November 29th, 2025

Discovery about brain receptors may open the door to new Alzheimer's treatments
Researchers at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two receptors in the brain that control the breakdown of amyloid beta, a substance that accumulates in Alzheimer's disease. According to the researchers, the study could pave the way for future drugs that are both safer and cheaper than current antibody treatments.
November 29, 2025 — Source

Health — Alzheimers — November 26th, 2025

Brain's GPS hasn't changed in millions of years: Specialized neurons may be vital to evolutionary survival
The same brain cells linked to disorientation in Alzheimer's disease have been preserved—and even slightly increased—across millions of years of evolution.
November 23, 2025 — Source

Cellular 'nanodomains' act as hidden hubs for protein clusters linked to ALS and dementia
Inside the cell reside many tiny assembly factories and warehouses that gather together all of the proteins and RNAs—which carry out instructions from our DNA—that a living being needs.
November 23, 2025 — Source or Source

Health — Alzheimers — November 23rd, 2025

Boosting one protein helps the brain protect itself from Alzheimer's
Researchers discovered that raising the protein Sox9 can help the brain's astrocytes clear out toxic plaque buildup linked to Alzheimer's. In mouse models that already showed memory problems, activating these cells improved cognitive performance. The treatment also reduced plaque levels over time. The work points toward a natural, cell-based way to slow Alzheimer's decline.
November 23, 2025 — Source

Health — Alzheimers — November 21st, 2025

Arginine supplementation curbs Alzheimer's disease pathology in animal models
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid &beta (A&beta) have recently been developed, their clinical effectiveness remains limited. These treatments can be costly and cause immune-related side effects, highlighting the need for safer, affordable, and widely accessible approaches that can slow the progression of AD.
November 21, 2025 — Source

Astrocyte-driven approach shows potential to reverse cognitive decline in Alzheimer's
Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the brains of mouse models of Alzheimer's disease and preserves cognitive function. The mechanism involves recruiting brain cells known as astrocytes, star shaped cells in the brain, to remove the toxic amyloid plaques that build up in many Alzheimer's disease brains. Increasing the production of Sox9, a key protein that regulates astrocyte functions during aging, triggered the astrocytes' ability to remove amyloid plaques.
November 21, 2025 — Source or Source

Chris Hemsworth and dad fight Alzheimer's with a trip down memory lane
Ars chats with director Tom Barbor-Might about new National Geographic documentary A Road Trip to Remember.
November 21, 2025 — Source or Watch Video

How the cheese-noodle principle could help counter Alzheimer's
Researchers at the Paul Scherrer Institute PSI have clarified how spermine—a small molecule that regulates many processes in the body's cells—can guard against diseases such as Alzheimer's and Parkinson's: It renders certain proteins harmless by acting a bit like cheese on noodles, making them clump together. This discovery could help combat such diseases.
November 21, 2025 — Source

Oral arginine reduces amyloid buildup in Alzheimer's models
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid &beta (A&beta) have recently been developed, their clinical effectiveness remains limited. These treatments can be costly and cause immune-related side effects, highlighting the need for safer, affordable, and widely accessible approaches that can slow the progression of AD.
November 21, 2025 — Source

Study clarifies how spermine can guard against Alzheimer's and Parkinson's
Researchers at the Paul Scherrer Institute PSI have clarified how spermine - a small molecule that regulates many processes in the body's cells - can guard against diseases such as Alzheimer's and Parkinson's: it renders certain proteins harmless by acting a bit like cheese on noodles, making them clump together. This discovery could help combat such diseases.
November 21, 2025 — Source

Health — Alzheimers — November 20th, 2025

Exercising in mid and later life can reduce dementia risk, new study suggests
For years, scientists have known that moving our bodies can sharpen our minds. Physical activity boosts blood flow to the brain, enhances neuroplasticity and reduces chronic inflammation. These processes are believed to protect against cognitive decline, including dementia.
November 20, 2025 — Source

Staying connected: How social ties can protect aging brains
"Social frailty" is a major dementia risk. A UNSW researcher is changing how to spot and treat it early.
November 20, 2025 — Source

Health — Alzheimers — November 13th, 2025

How income may shape risk of dementia
People with lower incomes and people from racial and ethnic historically underrepresented groups in clinical studies are more likely to have modifiable risk factors for dementia, factors that could be changed to lower their risk, according to a study published in Neurology.
November 13, 2025 — Source

Health — Alzheimers — November 8th, 2025

Scientists find brain cells that could stop Alzheimer's
Researchers have identified special immune cells in the brain that help slow Alzheimer's. These microglia work to reduce inflammation and block the spread of harmful proteins. They appear to protect memory and brain health, offering a promising new direction for therapy.
November 8, 2025 — Source

Health — Alzheimers — November 7th, 2025

Why Alzheimer's patients forget loved ones
UVA's Harald Sontheimer, graduate student Lata Chaunsali and their colleagues found that when protective structures around brain cells break down, people may lose the ability to recognize loved ones. In lab studies, keeping these structures intact helped mice remember one another.
November 7, 2025 — Source

Health — Alzheimers — November 6th, 2025

5,000 steps a day may slow Alzheimer's-related brain changes
New research reveals that even modest daily walking can slow the buildup of Alzheimer's-linked proteins and delay cognitive decline, giving older adults a realistic path to protect their memory and independence.
November 6, 2025 — Source

Health — Alzheimers — November 5th, 2025

Alzheimer's can hijack communication between brain and fat tissue, potentially worsening metabolic health
Alzheimer's disease disrupts communication between nerves and blood vessels in fat tissue, impairing autonomic regulation of metabolism. This interference may worsen metabolic and cardiovascular conditions such as diabetes, heart disease, and stroke, providing insight into the broader health complications observed in individuals with Alzheimer's.
November 5, 2025 — Source

Nanobodies from camels and llamas offer promise for treating schizophrenia and Alzheimer's disease
Nanobodies—tiny proteins derived from animals in the camelid family including camels, llamas, and alpacas—could be useful in treating brain disorders like schizophrenia and Alzheimer's disease.
November 5, 2025 — Source

Protective microglia subtype offers potential therapeutic pathway in Alzheimer's disease
A distinct microglia subtype characterized by reduced PU.1 and co-expression of CD28 limits neuroinflammation and slows amyloid and tau pathology in Alzheimer's disease. Lowering PU.1 enhances protective microglial functions, while loss of CD28 increases inflammation and plaque growth. These findings highlight the PU.1--CD28 axis as a potential target for microglia-based immunotherapies.
November 5, 2025 — Source

Researchers discover why living in a deprived neighborhood may raise dementia risk
Cambridge researchers have discovered why living in a disadvantaged neighborhood may be linked to an increase in an individual's risk of dementia.
November 5, 2025 — Source

Shared synaptic mechanism for Alzheimer's and Parkinson's disease unlocks new treatment possibilities
A shared molecular cascade in Alzheimer's and Parkinson's diseases disrupts synaptic vesicle recycling by causing excess microtubule formation, which sequesters dynamin and impairs vesicle retrieval. This synaptic dysfunction underlies both memory and motor symptoms, highlighting common therapeutic targets such as protein accumulation, microtubule overproduction, and microtubule-dynamin interaction.
November 5, 2025 — Source

Study sheds light on how Alzheimer's disease may contribute to larger health issues
A recent study from Houston Methodist sheds light on how Alzheimer's disease may contribute to larger health issues by hijacking the body's ability to regulate its metabolism. Researchers have discovered that along with the negative effects an Alzheimer's diagnosis brings, the disease can also sabotage messages between nerves and blood vessels in fat tissue, which can worsen heart and metabolic conditions such as stroke, heart disease and diabetes.
November 5, 2025 — Source

Health — Alzheimers — October 31st, 2025

Predicting the risk of heart disease and dementia in older adults: Q&A
More than 70% of people over 70 years old will one day develop cardiovascular disease, highlighting the need for effective diagnosis, treatment, and care for this population.
October 31, 2025 — Source

Health — Alzheimers — October 30th, 2025

How guided cognitive training may improve brain performance
The University of Texas at Arlington is expanding its research on brain health, focusing on how people navigate their surroundings and remember information. The findings could lead to improved strategies for enhancing brain function and slowing cognitive decline in conditions such as Alzheimer's disease.
October 30, 2025 — Source

Study finds more commonalities between CTE and Alzheimer's disease at the genetic level
Chronic traumatic encephalopathy (CTE) -- most often found in athletes playing contact sports -- is known to share similarities with Alzheimer's disease (AD), namely the buildup of a protein called tau in the brain. New research published today in Science finds even more commonalities between the two at the genetic level, showing CTE (like AD) is linked to damage to the genome and not just caused by repeated head impact (RHI).
October 30, 2025 — Source

Health — Alzheimers — October 24th, 2025

Popular cholesterol drugs may help prevent dementia
A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The research simulated the effects of cholesterol-lowering drugs and showed up to an 80% lower risk for certain genetic profiles. Scientists believe high cholesterol may contribute to dementia through atherosclerosis and small blood clots. Long-term trials could confirm whether medications can replicate this protective effect.
October 24, 2025 — Source

Health — Alzheimers — October 20th, 2025

Helpline support eases stress for dementia caregivers
Telephone-based helpline consultations significantly improve dementia caregivers' ability to manage stress and negative emotions. Caregivers with lower initial emotional management are more likely to seek multiple consultations. Early screening can help identify those needing additional support. The most common caregiver needs include service information, communication strategies, and emotional support.
October 20, 2025 — Source

Social and environmental inequality linked to risk of Alzheimer's
Where you live could shape how your brain ages, with neighborhood inequality and environmental stressors leaving measurable biological traces linked to Alzheimer's disease.
October 20, 2025 — Source

Health — Alzheimers — October 15th, 2025

Cellular railroad switches: How the brain routes supplies to build memories
Rab4 and Rab10 proteins act as opposing switches to regulate the delivery of supplies needed for synaptic potentiation during memory formation. Rab4 activation enhances delivery of neurotransmitter receptors to neural connections, while Rab10 activation diverts them away. These mechanisms are crucial for synaptic plasticity and may inform strategies for Alzheimer's disease resilience.
October 15, 2025 — Source

Eye-tracking offers measure of change in pre-clinical Alzheimer's disease
The effectiveness of eye-tracking technology in identifying people who have a genetic tendency to Alzheimer's disease, years before their symptoms show, has been highlighted in new research.
October 15, 2025 — Source

New brain imaging technique can detect early frontotemporal dementia
An advanced MRI technique measuring water molecule diffusion in brain gray matter can detect microstructural changes associated with hereditary frontotemporal dementia (FTD) before brain atrophy or symptoms appear. This method is more sensitive than traditional imaging, enabling earlier identification of at-risk individuals and monitoring of disease progression.
October 15, 2025 — Source

People with dementia less likely to be referred to allied health services by GPs
People with dementia are significantly less likely to be referred by general practitioners to allied health services compared to individuals with stroke or Parkinson's disease. Despite evidence supporting allied health interventions for dementia, referral rates remain low, indicating a need for improved awareness, care pathways, policy support, and workforce training in dementia care.
October 15, 2025 — Source

Health — Alzheimers — October 13th, 2025

Cholesterol-lowering drugs could reduce risk of dementia, study finds
Low cholesterol can reduce the risk of dementia, a new University of Bristol-led study with more than a million participants has shown.
October 13, 2025 — Source

Health — Alzheimers — October 10th, 2025

Dementia drug raises stroke risk—even in 'low-risk' patients, study shows
A major U.K. study of more than 165,000 dementia patients has found that risperidone raises stroke risk without exception, challenging safety assumptions by leaving no "safe group."
October 10, 2025 — Source

Health — Alzheimers — October 8th, 2025

Gold nanoparticle nasal spray delivers lithium safely to the brain
A new gold nanoparticle nasal spray delivers lithium directly to the brain, targeting Alzheimer's and bipolar disorder while avoiding harmful side effects.
October 8, 2025 — Source

Largest study of African American brain tissue reveals key Alzheimer gene activity
The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry (EA) individuals living in the U.S. Some of this is due to social determinants of health such as disparities in health care access and quality of education, biases in testing and higher rates of AD risk factors such as cardiovascular disease and diabetes in those who identify as African American.
October 8, 2025 — Source or Source

Rethinking Alzheimer's: Why this common gene variant is bad for your brain
The suspected causes of Alzheimer's disease are diverse, and its cures are, today, nonexistent.
October 8, 2025 — Source

Scientists Just Reversed Alzheimer's in Mice. Could They Do It in Humans?
Instead of targeting neurons, the researchers specifically sought to repair a critical part of the brain that keeps disease-inducing toxins out.
October 8, 2025 — Source

Health — Alzheimers — September 29th, 2025

HIV mystery uncovered: How the virus reprograms host cells to create perfect hiding places
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve.
September 29, 2025 — Source

New evidence shows blood-brain barrier remains intact in Alzheimer's mouse model
Scientists at TTUHSC found the blood-brain barrier remains largely intact in a mouse model of Alzheimer's disease, challenging previous assumptions about drug delivery.
September 29, 2025 — Source or Source

Q&A: Expert discusses role in brain health, impact of Prop 14
Chemistry is essential for understanding the molecular mechanisms of neurodegenerative diseases, such as protein misfolding and amyloid aggregation in Alzheimer's and Parkinson's. Advanced chemical tools enable real-time study of these processes, informing drug design. State investment through Proposition 14 could accelerate research and translation of basic discoveries into clinical therapies in Texas.
September 29, 2025 — Source

Fiber-optic method allows real-time monitoring of Alzheimer's plaques in freely behaving mice
Alzheimer's disease is marked by the buildup of amyloid plaques in the brain, but most ways of studying these deposits in mouse models require sacrificing the animals. That limits researchers' ability to follow how the disease develops or how treatments work over time.
September 29, 2025 — Source

How gene mutations drive dementia in Parkinson's disease
Parkinson's disease causes both movement and cognitive deficits, and for a long time both were thought to be caused by the accumulation of a protein called alpha-synuclein in the brain. But a new Nature Communications study has found that the cognitive deficits arise through a different—and unexpected—mechanism.
September 29, 2025 — Source

Health — Alzheimers — September 26th, 2025

Breakthrough in predicting Parkinson's and dementia in people with REM sleep behavior disorder
An international research team led by Universite de Montreal medical professor Shady Rahayel has made a major breakthrough in predicting neurodegenerative diseases.
September 26, 2025 — Source

EU approves contentious Alzheimer's medication
The European Union on Thursday approved the highly contentious Alzheimer's medication Kisunla under strict conditions, with the drug's effectiveness hotly debated by the medical community.
September 26, 2025 — Source

Isolated REM sleep behavior disorder may predict Parkinson's disease and dementia
Imaging biomarkers in individuals with isolated REM sleep behavior disorder (iRBD) can predict future development of Parkinson's disease or dementia with Lewy bodies. Reduced glymphatic function in the left brain hemisphere increases Parkinson's risk, while elevated free water in the basal nucleus of Meynert signals higher risk for dementia with Lewy bodies.
September 26, 2025 — Source

Health — Alzheimers — September 25th, 2025

AstroCapsules offer a new way to reduce brain inflammation
Neuroinflammation is linked to a host of detrimental brain disorders, including Alzheimer's and Parkinson's disease. A collaborative research team from Houston Methodist and Rice University has developed a way to fight back with a tiny, bioengineered system to deliver anti-inflammatory proteins to specific targets in the brain.
September 25, 2025 — Source

New protein interaction map sheds light on how brain cell communication breaks down in Alzheimer's disease
A new study led by the Icahn School of Medicine at Mount Sinai offers one of the most comprehensive views yet of how brain cells interact in Alzheimer's disease, mapping protein networks that reveal communication failures and point to new therapeutic opportunities.
September 25, 2025 — Source

Tiny treatment system helps fight back against neuroinflammation in the brain
Neuroinflammation is linked to a host of detrimental brain disorders, including Alzheimer's and Parkinson's disease. A collaborative research team from Houston Methodist and Rice University has developed a way to fight back with a tiny, bioengineered system to deliver anti-inflammatory proteins to specific targets in the brain.
September 25, 2025 — Source

Health — Alzheimers — September 16th, 2025

Age influences amyloid positivity in Parkinson's disease without dementia
A new research paper was published in Volume 17, Issue 8 of Aging-US on August 6, 2025, titled "Age-related trends in amyloid positivity in Parkinson's disease without dementia."
September 16, 2025 — Source

Building bridges between Alzheimer's theories: Amyloid beta and inflammation converge on the same receptor
If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between them, ultimately destroying the neural networks that underlie our memories.
September 16, 2025 — Source

Lifestyle changes show promise in preventing cognitive decline and Alzheimer's disease
An estimated 7.2 million Americans over age 65 currently live with Alzheimer's disease (AD). That number is expected to nearly double to 13.8 million by 2060. These increases reflect more than demographic shifts; they point to a growing public health crisis that requires a new, proactive approach. While chronological age is the strongest known risk factor for cognitive decline, losing cognitive function is not an inevitable part of aging.
September 16, 2025 — Source

Training hospital staff in person-centered dementia care improves recovery outcomes
A new study led by Prof. Lynn Chenoweth from UNSW's Center for Healthy Brain Aging (CHeBA) has shown that educating hospital staff in person-centered dementia care leads to better care experiences, greater staff confidence, and improved rehabilitation outcomes for older Australians.
September 16, 2025 — Source

Health — Alzheimers — September 9th, 2025

Brain iron levels detected by MRI can predict cognitive impairment and decline
A special MRI technique that detects iron levels in different regions of the brain can predict the onset of mild cognitive impairment and cognitive decline in cognitively unimpaired older adults, potentially creating a pathway to earlier interventions, according to a study published in Radiology.
September 9, 2025 — Source

Changing indoor environments could improve sleep for people living with dementia
Implementing changes to indoor environments, such as cooler bedrooms at night and increasing the amount of bright light during the day, could significantly improve sleep for people living with dementia, according to a study led by the University of Surrey.
September 9, 2025 — Source

How fat disables the brain's immune shield in Alzheimer's disease 
It was long thought that fat in the brain played no role in neurodegenerative diseases, but Purdue University researchers are challenging that assumption.
September 9, 2025 — Source

Research reveals a promising new target to thwart Alzheimer's decades before symptoms star
A person will have Alzheimer's years before ever knowing it. The disorienting erasure of memories, language, thoughts—in essence, all that makes up one's unique sense of self—is the final act of this enigmatic disease that spends decades disrupting vital processes and dismantling the brain's delicate structure.
September 9, 2025 — Source

Study of identical twins links faster aging to memory decline
New research from University of Virginia psychologists has found that "epigenetic clocks"—tools scientists use to estimate a person's biological age—can predict cognitive decline. The study, which focused on middle-aged twins, also found socioeconomic status plays a role.
September 9, 2025 — Source

Zero-burden technologies show that brighter days and cooler nights could improve sleep in dementia
Implementing changes to indoor environments, such as cooler bedrooms at night and increasing the amount of bright light during the day, could significantly improve sleep for people living with dementia, according to a study led by the University of Surrey.
September 9, 2025 — Source

Health — Alzheimers — September 4th, 2025

A 3-minute brainwave test could spot Alzheimer's years before symptoms
A quick brainwave test called Fastball can detect early signs of Alzheimer's at home, opening the door to faster diagnoses and treatments.
September 4, 2025 — Source

Building bridges in a memory care desert
In rural and underserved areas—particularly Native American communities—early signs of dementia often go unrecognized. This could be because access to specialized care is limited, and symptoms are easily mistaken for normal memory loss due to aging.
September 4, 2025 — Source

Gene variant slows down removal of debris in the brain, increasing Alzheimer's risk, say researchers
A type of brain cell that plays a vital role in maintaining neural networks and repairing injuries lies at the core of a promising new study on Alzheimer's disease from the USF Health Byrd Alzheimer's Center and Research Institute.
September 4, 2025 — Source

Higher education provides limited protection from Alzheimer's disease
Cognitive reserve (CR) is the brain's ability to maintain cognitive function despite age-related brain changes, damage or disease. It reflects an individual's capacity to cope with these changes by utilizing pre-existing cognitive strategies or developing compensatory mechanisms.
September 4, 2025 — Source

Smell loss emerges as the early behavioural sign of Alzheimer's
ew research reveals that immune cells attack brainstem nerve fibers linked to smell, making loss of smell the earliest detectable sign of Alzheimer's disease, and a potential window for earlier diagnosis.
September 4, 2025 — Source

Health — Alzheimers — September 1st, 2025

'Young' immune cells reverse signs of neurodegenerative brain changes in preclinical study
"Young" immune cells created by Cedars-Sinai investigators reversed signs of aging and Alzheimer's disease in the brains of laboratory mice, according to a study published in the journal Advanced Science.
September 1, 2025 — Source

Alzheimer — Resources

Alzheimer's Association
Our vision is a world without Alzheimer's disease
Provides Information — Source